Elena Ridloff - Net Worth and Insider Trading
Elena Ridloff Net Worth
The estimated net worth of Elena Ridloff is at least $191,729 dollars as of 2024-11-13. Elena Ridloff is the EVP and CFO of ACADIA Pharmaceuticals Inc and owns about 10,553 shares of ACADIA Pharmaceuticals Inc (ACAD) stock worth over $189,321. Elena Ridloff is also the Director of Kronos Bio Inc and owns about 2,630 shares of Kronos Bio Inc (KRON) stock worth over $2,409. Details can be seen in Elena Ridloff's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elena Ridloff has not made any transactions after 2021-04-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Elena Ridloff
Elena Ridloff Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Elena Ridloff owns 3 companies in total, including Kronos Bio Inc (KRON) , ACADIA Pharmaceuticals Inc (ACAD) , and Kymera Therapeutics Inc (KYMR) .
Click here to see the complete history of Elena Ridloff’s form 4 insider trades.
Insider Ownership Summary of Elena Ridloff
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KRON | Kronos Bio Inc | 2020-10-14 | director |
| ACAD | ACADIA Pharmaceuticals Inc | 2021-04-30 | EVP and CFO |
| KYMR | Kymera Therapeutics Inc | 2021-03-12 | director |
Elena Ridloff Latest Holdings Summary
Elena Ridloff currently owns a total of 2 stocks. Among these stocks, Elena Ridloff owns 10,553 shares of ACADIA Pharmaceuticals Inc (ACAD) as of April 30, 2021, with a value of $189,321 and a weighting of 98.74%. Elena Ridloff also owns 2,630 shares of Kronos Bio Inc (KRON) as of October 14, 2020, with a value of $2,409 and a weighting of 1.26%.
Latest Holdings of Elena Ridloff
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACAD | ACADIA Pharmaceuticals Inc | 2021-04-30 | 10,553 | 17.94 | 189,321 |
| KRON | Kronos Bio Inc | 2020-10-14 | 2,630 | 0.92 | 2,409 |
Holding Weightings of Elena Ridloff
Elena Ridloff Form 4 Trading Tracker
According to the SEC Form 4 filings, Elena Ridloff has made a total of 5 transactions in ACADIA Pharmaceuticals Inc (ACAD) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in ACADIA Pharmaceuticals Inc is the sale of 1,032 shares on April 30, 2021, which brought Elena Ridloff around $20,981.
According to the SEC Form 4 filings, Elena Ridloff has made a total of 1 transactions in Kronos Bio Inc (KRON) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kronos Bio Inc is the acquisition of 2,630 shares on October 14, 2020, which cost Elena Ridloff around $49,970.
Insider Trading History of Elena Ridloff
- 1
Elena Ridloff Trading Performance
GuruFocus tracks the stock performance after each of Elena Ridloff's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Elena Ridloff is 1.24%. GuruFocus also compares Elena Ridloff's trading performance to market benchmark return within the same time period. The performance of stocks bought by Elena Ridloff within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Elena Ridloff's insider trading performs compared to the benchmark.
Performance of Elena Ridloff
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.66 | | | | | |
| Relative Return to S&P 500(%) | -14.43 | | | | | |
Elena Ridloff Ownership Network
Ownership Network List of Elena Ridloff
Ownership Network Relation of Elena Ridloff
Elena Ridloff Owned Company Details
What does Kronos Bio Inc do?
Who are the key executives at Kronos Bio Inc?
Elena Ridloff is the director of Kronos Bio Inc. Other key executives at Kronos Bio Inc include director & 10 percent owner & President & CEO Norbert W Bischofberger , COO & General Counsel Barbara Kosacz , and Chief Scientific Officer Christopher Dinsmore .
Kronos Bio Inc (KRON) Insider Trades Summary
Over the past 18 months, Elena Ridloff made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net purchase of 5,351,696 shares made by Norbert W Bischofberger , a net sale of 40,194 shares made by Jorge Dimartino , and a net sale of 24,032 shares made by Christopher Dinsmore .
In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,028 shares of Kronos Bio Inc (KRON) were sold and 5,351,696 shares were bought by its insiders, resulting in a net purchase of 5,235,668 shares.
Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kronos Bio Inc Insider Transactions
Elena Ridloff Mailing Address
Above is the net worth, insider trading, and ownership report for Elena Ridloff. You might contact Elena Ridloff via mailing address: C/o Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
